Works matching IS 13524585 AND DT 2021 AND VI 27 AND IP 14
Results: 23
Juxtacortical susceptibility changes in progressive multifocal leukoencephalopathy at the gray–white matter junction correlates with iron-enriched macrophages.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2159, doi. 10.1177/1352458521999651
- By:
- Publication type:
- Article
Keep your eyes on the prize: Tackling breakthrough COVID-19 in MS patients.
- Published in:
- 2021
- By:
- Publication type:
- Editorial
Humoral immune response after COVID-19 in multiple sclerosis: A nation-wide Austrian study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2209, doi. 10.1177/13524585211049391
- By:
- Publication type:
- Article
Air pollution is a risk factor for multiple sclerosis – Commentary.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2140, doi. 10.1177/13524585211046352
- By:
- Publication type:
- Article
Serious side effects of amantadine: Rethinking the benefits and risks of medications for MS fatigue.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2290, doi. 10.1177/13524585211042341
- By:
- Publication type:
- Article
Air pollution is a risk factor for multiple sclerosis – Yes.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2137, doi. 10.1177/13524585211035953
- By:
- Publication type:
- Article
Delayed amantadine toxicity causing apparent progression of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2288, doi. 10.1177/13524585211035737
- By:
- Publication type:
- Article
Air pollution is a risk factor for multiple sclerosis – No.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2138, doi. 10.1177/13524585211026875
- By:
- Publication type:
- Article
Late-onset cutaneous reaction to BNT162b2 mRNA COVID-19 vaccine in an immunocompromised patient.
- Published in:
- 2021
- By:
- Publication type:
- Letter
Home-based Pilates for symptoms of anxiety, depression and fatigue among persons with multiple sclerosis: An 8-week randomized controlled trial.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2267, doi. 10.1177/13524585211009216
- By:
- Publication type:
- Article
Male fertility in relapsing-remitting multiple sclerosis patients treated with natalizumab and ocrelizumab: A prospective case-control study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2284, doi. 10.1177/13524585211009208
- By:
- Publication type:
- Article
Multiple sclerosis: Is there a risk of worsening after yellow fever vaccination?
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2280, doi. 10.1177/13524585211006372
- By:
- Publication type:
- Article
Utilising multi-large omics data to elucidate biological mechanisms within multiple sclerosis genetic susceptibility loci.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2141, doi. 10.1177/13524585211004422
- By:
- Publication type:
- Article
Longitudinal analysis of T1w/T2w ratio in patients with multiple sclerosis from first clinical presentation.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2180, doi. 10.1177/13524585211003479
- By:
- Publication type:
- Article
Anti-CD20 therapy corrects a CD8 regulatory T cell deficit in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2170, doi. 10.1177/13524585211003301
- By:
- Publication type:
- Article
Cervical cord myelin abnormality is associated with clinical disability in multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2191, doi. 10.1177/13524585211001780
- By:
- Publication type:
- Article
Disability improvement as a clinically relevant outcome in clinical trials of relapsing forms of multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2219, doi. 10.1177/13524585211000280
- By:
- Publication type:
- Article
Brain MRI activity during the year before pregnancy can predict post-partum clinical relapses.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2232, doi. 10.1177/13524585211002719
- By:
- Publication type:
- Article
Cognitive impairment, the central vein sign, and paramagnetic rim lesions in RIS.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2199, doi. 10.1177/13524585211002097
- By:
- Publication type:
- Article
Childhood obesity and multiple sclerosis: A Mendelian randomization study.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2150, doi. 10.1177/13524585211001781
- By:
- Publication type:
- Article
Alemtuzumab treatment in Denmark: A national study based on the Danish Multiple Sclerosis Registry.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2254, doi. 10.1177/13524585211003291
- By:
- Publication type:
- Article
A randomized study of natalizumab dosing regimens for relapsing–remitting multiple sclerosis.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2240, doi. 10.1177/13524585211003020
- By:
- Publication type:
- Article
COVID-19 in patients with multiple sclerosis undergoing disease-modifying treatments.
- Published in:
- Multiple Sclerosis Journal, 2021, v. 27, n. 14, p. 2126, doi. 10.1177/1352458520971817
- By:
- Publication type:
- Article